# Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

> clinical trial · VERIFIED · 2026-08-04

Status: RECRUITING · Sponsor: Tempus AI · Condition: Pulmonary Hypertension

- Company: Tempus AI
- Sector: digital health
- Primary source: https://clinicaltrials.gov/study/NCT06911632

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.